Aquestive Therapeutics, Inc.
- AQST
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Oral Film Drug Delivery
- Specialty Pharma
$3.78
Today −6.90%Quote Oct 16, 2026, 08:00 PM UTC
−18.88%over the last month
Max drawdown −23.6%From 1-month high −23.6%3 months −4.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$474.4M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$10.50
+177.8% from here
Floor
$3.55
6.2% below price
Where the price sits
10 analysts
Analyst range, low to high
$10.00$11.00
- Price $3.78
- Resistance $3.80
- Consensus $10.50
The price is right under resistance. Analysts' average target sits about 178% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AQSTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $13.8M
- Manufacture and Supply Revenue$11.9M86.2%
- License and Royalty Revenue$1.3M9.6%
- Co-Development and Research Fees$582,0004.2%
Industry
Drug Manufacturers - Specialty & Generic
Employees
147